Log in or Sign up for Free to view tailored content for your specialty!
Pulmonology News
Topline results: Winrevair lowers risk for mortality in patients with advanced PAH
Adults with pulmonary arterial hypertension functional class three or four faced a decreased risk for all-cause mortality or morbidity events with Winrevair vs. placebo, according to phase 3 ZENITH trial topline results.
Frailty negatively impacts lung function, survival in patients with IPF
Significant predictors of FVC and diffusion capacity of lung for carbon monoxide included frailty, low fat-free mass index and sarcopenia in patients with idiopathic pulmonary fibrosis, according to data published in Respiratory Research.
Log in or Sign up for Free to view tailored content for your specialty!
Life insurance 101: Understand term vs. permanent policies
Physicians generally use life insurance to achieve certain wealth planning goals — from protecting the family against the risk of a breadwinner’s early death to providing an estate for heirs and more.
Evidence limited for predicting, monitoring COPD exacerbations via wearable devices
PHILADELPHIA — Despite the growing prevalence of wearable devices, more research is needed before they can be used to predict and monitor COPD exacerbations, according to a presentation at the 2024 GOLD COPD International Conference.
FDA clears investigational new drug application for inhaled nicotine replacement therapy
The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN-01), an inhaled nicotine replacement therapy, according to a press release.
Lack of primary care clinician a barrier to lung cancer screening
Lack of a primary care provider may hinder an individual’s ability to undergo lung cancer screening, according to results of a quality improvement study.
1 in 20 adult outpatients hospitalized after RSV diagnosis
Among outpatients with respiratory syncytial virus, one in 20 experienced all-cause hospitalization, according to a recent study.
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
The life expectancy gap in the United States widened to over 20 years in the last 2 decades, with significant variations in life expectancy across diverse populations, study results published in The Lancet revealed.
Cystic fibrosis triple therapy improves clinical outcomes in N1303K mutation
Percent-predicted FEV1 and respiratory-related quality of life improved with 28-day triple therapy in individuals with the N1303K cystic fibrosis transmembrane conductance defect, according to data published in Lancet Respiratory Medicine.
Even with treatment, patients with COPD regularly become frequent exacerbators
BOSTON — Moving from Global Initiative for Chronic Obstructive Lung Disease, or GOLD, group A/B to group E was common among patients starting a new inhaled maintenance medication, according to a presentation at the CHEST Annual Meeting.
-
Headline News
Does the world still need an HIV vaccine? Experts say yes
November 27, 20247 min read -
Headline News
3-D holograms make virtual cancer care ‘truly engaging and emotional’
December 02, 20243 min read -
Headline News
Q&A: Stigma remains a substantial barrier to naloxone availability in US
December 02, 20242 min read
-
Headline News
Does the world still need an HIV vaccine? Experts say yes
November 27, 20247 min read -
Headline News
3-D holograms make virtual cancer care ‘truly engaging and emotional’
December 02, 20243 min read -
Headline News
Q&A: Stigma remains a substantial barrier to naloxone availability in US
December 02, 20242 min read